Dilbert Creator's Pluvicto Treatment Expedited After Trump Outreach
Dilbert Creator's Pluvicto Treatment Expedited After Trump Outreach

Dilbert Creator's Pluvicto Treatment Expedited After Trump Outreach

News summary

Scott Adams, creator of Dilbert, says he has metastatic prostate cancer and publicly appealed to President Trump after Kaiser Permanente of Northern California approved but had not scheduled his Pluvicto (Lu-177 PSMA) infusion while he said he was “declining fast.” Trump replied “On it!” on Truth Social, and aides and allies including Dan Scavino, Donald Trump Jr. and media personality Dr. Mehmet Oz, as well as Robert F. Kennedy Jr., engaged to help. Kaiser said its oncology team was working with Adams to schedule the infusion and noted its nuclear medicine and oncology experts have treated more than 150 patients with Pluvicto in Northern California. Adams later said the outreach likely saved his life and that he was getting what he needed, and by Monday he expressed gratitude as healthcare and administration contacts coordinated to expedite his care. Reporters emphasized that Pluvicto is FDA-approved but not a cure and noted questions about how high-level political intervention would practically affect access to treatment.

Story Coverage
Bias Distribution
54% Right
Information Sources
ee2e2e88-f60f-46ba-af3a-dd7892b6c73c0de89078-8bc1-4dae-b16e-c0e6d67fee74166bc319-c612-4063-955b-1bdc4fec97ff8fd16c14-0c8d-4cc5-976a-faa104e51a33
+9
Left 46%
Right 54%
Coverage Details
Total News Sources
16
Left
6
Center
0
Right
7
Unrated
3
Last Updated
19 days ago
Bias Distribution
54% Right
Related News
Ask VT AI
Story Coverage
Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Present

Gift Subscriptions

The perfect gift for understanding
news from all angles.

Related News
Recommended News